UTMD logo

UTAH MEDICAL PRODUCTS INC

UTMDNASDAQ
πŸ† #2990 by market capEarnings Oct 22US Equity
$71.94β–² $0.62 (+0.86%)
Market closed Β· at close
1hβ€”
24hβ–² 0.9%
7dβ–² 2.0%
14dβ–² 0.9%
30dβ–² 1.2%
1yβ–² 29.1%
🏦Market Cap
$229M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-5.8%
Declining
πŸ“ŠGross Margin
54.9%
Healthy
πŸ’΅FCF Margin
28.2%
Strong
βš–οΈP/S Ratio
6.3x
Fair
Otter Score
66
Fair

Trading Snapshot

Day Range
$70.94 – $73.08
52-Week Range
$53.66 – $75.75
Volume
$4.30B
Avg Volume
$4.92B
Shares Outstanding
3.2M
Next Earnings
Oct 20, 2026

Fundamentals Snapshot

Annual Revenue
$39M
Last Q Revenue
$9M
P/E Ratio
22.3
P/S Ratio
6.3x
EPS (TTM)
$3.29
Dividend Yield
1.72%

Why Investors Own UTMD

  • βœ“High-growth profile β€” revenue up +1.5% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 73% gross margin and 25% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$39Mβ–Ό βˆ’1.5% YoY
Gross Margin (TTM)
72.6%β–² +3.6% YoY
Operating Income (TTM)
$10Mβ–Ό βˆ’1.5% YoY
Free Cash Flow (TTM)
$10Mβ–Ό βˆ’1.5% YoY

About UTAH MEDICAL PRODUCTS INC

Utah Medical Products, Inc. (UTMD) is a healthcare technology company focused on the creation, production, and supply of medical devices for the healthcare sector. UTMD offers a comprehensive portfolio of medical devices primarily serving labor and delivery departments and neonatal intensive care units. Key offerings include fetal monitoring accessories, vacuum-assisted delivery systems, and other specialized tools for childbirth. For newborns, they provide respiratory hoods (DISPOSA-HOOD), umbilical vessel catheters (GESCO), silicone oral protection devices (PALA-NATE), and lumbar sampling kits (MYELO-NATE). Beyond maternity care, the company supplies blood pressure monitoring systems (DELTRAN PLUS), disposable peritoneal dialysis sets (DIALY-NATE), urinary drainage systems (URI-CATH), and feeding devices (NUTRI-CATH/NUTRI-LOK). They also manufacture HEMO-NATE disposable filters, various catheterization procedure trays, and DELTRAN disposable pressure transducers along with related accessories and molded parts. A substantial portion of UTMD's offerings targets women's health and gynecological interventions. This includes advanced electrosurgical solutions like the LETZ system for cervical lesion excision, paired with FINESSE+ generators and various specialized electrodes (loop, ball, needle), and FILTRESSE evacuators. They also provide laparoscopic instruments (Femcare line), including trocars and cannulae, alongside EPITOME and OptiMicro electrosurgical devices. Complementing these are products for surgical contraception (Filshie Clip), endoscopic irrigation (PATHFINDER PLUS), suprapubic catheterization, and urinary incontinence management (LIBERTY systems). Specialized tools for uterine assessment and sampling, such as the ENDOCURETTE and TVUS/HSG-Cath, as well as the LUMIN uterine manipulator for laparoscopic procedures, complete this extensive portfolio. UTMD's diverse product range serves various healthcare settings, including neonatal intensive care units, labor and delivery wards, women's health centers within hospitals, outpatient clinics, and physicians' offices. The company facilitates distribution through a combination of direct customer service and sales teams, independent consultants, and manufacturer representatives. Established in 1978, Utah Medical Products, Inc. maintains its headquarters in Midvale, Utah.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
66/100

Analyst Price Target

β“˜
Average Target
$95.84
β–² +33.2% Upside
High Target$116.76
Low Target$77.51
Based on 13 analysts

Latest News & Updates